Covestor’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111K Buy
1,409
+171
+14% +$14.5K 0.06% 300
2026
Q1
$107K Sell
1,238
-3,505
-74% -$315K 0.07% 262
2025
Q4
$414K Sell
4,743
-138
-3% -$10.5K 0.22% 59
2025
Q3
$280K Buy
4,881
+4,139
+558% +$238K 0.15% 101
2025
Q2
$44K Buy
742
+357
+93% +$23.1K 0.03% 937
2025
Q1
$28K Sell
385
-82
-18% -$6.78K 0.02% 1068
2024
Q4
$39K Buy
467
+109
+30% +$8.6K 0.02% 943
2024
Q3
$26K Sell
358
-957
-73% -$67.6K 0.02% 1118
2024
Q2
$90K Sell
1,315
-928
-41% -$55.4K 0.06% 560
2024
Q1
$120K Buy
2,243
+252
+13% +$13.5K 0.08% 408
2023
Q4
$106K Buy
1,991
+167
+9% +$8.14K 0.07% 458
2023
Q3
$91K Buy
1,824
+101
+6% +$5.65K 0.07% 474
2023
Q2
$103K Buy
1,723
+279
+19% +$15.9K 0.08% 419
2023
Q1
$82K Buy
1,444
+3
+0.2% +$192 0.07% 488
2022
Q4
$107K Sell
1,441
-235
-14% -$16K 0.09% 348
2022
Q3
$100K Buy
1,676
+1,194
+248% +$71.9K 0.09% 350
2022
Q2
$27K Sell
482
-303
-39% -$19.9K 0.02% 919
2022
Q1
$58K Buy
785
+364
+86% +$25.3K 0.04% 754
2021
Q4
$30K Buy
+421
New +$30.6K 0.04% 755

Other funds holding GMED

Covestor's GMED Position: Q2 2026 in Review

Covestor increased its Globus Medical (GMED) stake by 14% in Q2 2026, buying an estimated $14.5K and bringing the position to 1,409 shares worth $111K. The position accounts for 0.06% of the portfolio, ranked #300.

Covestor first reported a position in GMED in Q4 2021 and has held it in 19 quarters since. The position peaked at $414K in Q4 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Covestor held 1,409 shares of Globus Medical worth $111K as of Q2 2026.
  • Covestor bought 171 Globus Medical shares in Q2 2026, an estimated $14.5K.
  • Globus Medical made up 0.06% of Covestor's portfolio in Q2 2026, its #300 holding.
  • Covestor first reported a position in Globus Medical in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Globus Medical position peaked at $414K in Q4 2025.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.